Efficacy of mRNA, adenoviral vector, and perfusion protein COVID-19 vaccines MR Zinatizadeh, PK Zarandi, M Zinatizadeh, MH Yousefi, J Amani, ... Biomedicine & Pharmacotherapy 146, 112527, 2022 | 52 | 2022 |
SARS-CoV-2: from the pathogenesis to potential anti-viral treatments PK Zarandi, MR Zinatizadeh, M Zinatizadeh, MH Yousefi, N Rezaei Biomedicine & Pharmacotherapy 137, 111352, 2021 | 36 | 2021 |
The role of host miRNAs on Mycobacterium tuberculosis A Behrouzi, M Alimohammadi, AH Nafari, MH Yousefi, F Riazi Rad, ... ExRNA 1 (1), 1-10, 2019 | 27 | 2019 |
Exosomes in tuberculosis: Still terra incognita? S Hadifar, A Fateh, MH Yousefi, SD Siadat, F Vaziri Journal of cellular physiology 234 (3), 2104-2111, 2019 | 18 | 2019 |
The role of ral signaling and post translational modifications (PTMs) of Ras in cancer MR Zinatizadeh, PK Zarandi, M Keshavarz-Fathi, MH Yousefi, N Rezaei Genome Instability & Disease 3 (1), 22-32, 2022 | 2 | 2022 |
An Overview of the Mitogenic RAS Effectors and its Therapeutic Approaches PK Zarandi, MR Zinatizadeh, MH Yousefi, HR Mirzaei, ME Akbari | | |